Keymed Biosciences announces 2022 annual results: Efficiently driving clinical progress and proactively expanding global strategic collaboration
Chengdu, China, March 18, 2023 (Reuters) /PRNewswire/ – CHENGDU, China, March 18, 2023 /PRNewswire/– Keymed Biosciences Inc. (HKEX: 02162) announced its 2022 full-year results. The Company focused on unmet clinical needs and continued to efficiently develop innovative and differentiated pipelines, proactively execute global strategic collaborations and accelerate its commercialization progressions in 2022. Development of innovative … Read more